Cyra Nargolwalla

Cyra Nargolwalla is Member of the Board of Directors of the Plasseraud IP Group. 

She is regularly recognized for her outstanding expertise in the fields of biotechnology and pharmaceuticals (vaccines, hormonal therapy, cancerology), as well as textiles, paper and the food industry. She has an excellent track record representing clients in Opposition and Appeal Proceedings before the EPO, in both French and English. Cyra also handles litigation matters in France and in other countries.

She is a regular speaker at conferences on biotech/pharmaceutical patent matters as well as on litigation-related topics. She has been invited to the EPO several times to speak with Examiners on how to provide better client satisfaction with respect to examination and opposition procedures. She also regularly takes part in discussions about oral proceedings before the EPO and is a staunch supporter of the EPO’s initiative to move to Oral Proceedings via videoconference, as she firmly believes that this improves access to justice for all parties. Cyra is one of two recognized IP experts invited by the President of the EPO as an ad personam member of the current SACEPO (Standing Advisory Committee European Patent Office) Working Party on Rules. She was previously an active member of SACEPO’s Working Party on Guidelines.

Particularly involved in professional associations, she is:
-    Vice-President of the Bureau of the French Group of AIPPI, and member of the Diversity & Inclusion Bureau Advisory Committee,
-    Co-President of the D&I Committee of the CNCPI,
-    Member of the APEB Executive Committee,
-    Member of IPO (Intellectual Property Owners Organization), and active in the European Practice Committee and the Diversity & Inclusion Committee,
-    Member of epi Working Group on Diversity & Inclusion.